<SEC-DOCUMENT>0001144204-12-033665.txt : 20120706
<SEC-HEADER>0001144204-12-033665.hdr.sgml : 20120706
<ACCEPTANCE-DATETIME>20120607113926
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001144204-12-033665
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20120607

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVELOS THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001279704
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				043321804
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		ONE GATEWAY CENTER, SUITE 504
		CITY:			NEWTON
		STATE:			MA
		ZIP:			02458
		BUSINESS PHONE:		617-244-1616

	MAIL ADDRESS:	
		STREET 1:		ONE GATEWAY CENTER, SUITE 504
		CITY:			NEWTON
		STATE:			MA
		ZIP:			02458

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COMMON HORIZONS INC
		DATE OF NAME CHANGE:	20040211
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="logo.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%; font-size: 10pt; font-weight: bold">Harry S. Palmin</TD>
    <TD STYLE="width: 33%; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 33%; font-size: 10pt; font-weight: bold">hpalmin@novelos.com</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>President and CEO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>VIA EDGAR</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities and Exchange Commission<BR>
Division of Corporation Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">450 Fifth Street, N.W.<BR>
Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">June 7, 2012</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%">&nbsp;</TD>
    <TD STYLE="width: 3%">Re:</TD>
    <TD STYLE="width: 88%">Novelos Therapeutics, Inc.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><U>Registration Statement on Form S-1 (File No. 333-180631)</U></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to Rule 461(a) under the Securities
Act of 1933, as amended, Novelos Therapeutics, Inc. (the &ldquo;Company&rdquo;) hereby requests that the effectiveness of the Company&rsquo;s
Registration Statement on Form S-1, as amended (File No. 333-180631) (the &ldquo;Registration Statement&rdquo;), be accelerated
so that the Registration Statement will become effective at 4:30 p.m., Eastern time, on Thursday, June 7, 2012, or as soon as practicable
thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company acknowledges that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose
the Commission from taking any action with respect to the filing;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does
not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by
the Commission or any person under the federal securities laws of the United States.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%">&nbsp;</TD>
    <TD STYLE="width: 18%">&nbsp;</TD>
    <TD STYLE="width: 49%">Very truly yours,</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Novelos Therapeutics, Inc.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>By: <U>/s/ Harry S. Palmin&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Harry S. Palmin, President and CEO</TD></TR>
</TABLE>


<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Novelos Therapeutics, Inc.</B> One Gateway
Center, Suite 504 Newton, MA 02458 617.244.1616 Fax 964.6331</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"``;`*D#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#IOB?X"\/C
M2C?6M@D&HWVI1))<AV)S+)\QP3CJ<]*\NTK5O$'PE\8S6T\3!<@3V['Y+B//
M#*?SP?J/45[M\2_^0!I__86M/_1@JYXV\$Z=XUT@VMTHCNHP3;7('S1M_53W
M%?58#-E2P\*6,]^G-R3OK:UK?=_PQA*G=WCN:7A[Q#I_B?1XM3TV820R<,/X
MHV[JP[$5YQX]^'?AF&[\/R6VGFW>_P!9CM[DQRM^\1PQ;J3@Y7MZFO,M+U3Q
M#\)/&$MO/&P7($]N3^[N(\\,/UP>W(]17L.O>(M.\4:?X,U+39A)"_B"V#+_
M`!1MLDRK#L:<LOK9=B8U,/-NE.]FGY-I.WX!SJ<;/<[C2-&T[P_IJV.EVHM[
M5"66)6)Y/)ZDUXCXG^-6NC4KNSTNVALHHV>'=*N^4$$C=UP"/Q%>I?$?Q5-X
M/\'S:E:^6;QI8X;<2(64L3DY`(_A#?CBO#?'5DFKZ9I_C:UV[-2`2\C3I%<`
M8/TSC.*^>G0KRH_6IZINU_/?^F:IJ_*;GA_XU^)/MMM:7EG;ZCYC)$H1?+D8
MD@=>A)^@%?05?,'@*.WT.TU#QCJ"*5L4,=@CCB6Y88&/7'?_`/57K?@_5--^
M*?@__B=6D,MY;%HIAM^XS*0'7.0"1T]"*=/!U)47B&O<3LW_`,`')7MU/1**
M^8=`6/P'\2&TGQ'8PSVIF""6>/)4;ODE1CT'3]<]*]O^(.F:;J_AT0W,$$]Y
M,PAL-[$?O7X!&",\<_A79C<K^JUH0Y^:,]5)+I]_3U)C/F3.OJI?:KIVF!#J
M%_:V@DSL^T3+'NQUQDC/45PVM+;?"?X:7+:,J"Y+(`9I"WF3-A2V#U(`S@>E
M9OPQ_L"UT5-=UG5]/FUZ_)DEGNKM&D13G"C<<KQU'^`J(Y>G1EB$VX)V5EJW
M^-E]X^?6QZ;9ZC8ZC&9+&\M[J,'!:"57`_$&J6N>&]'\1)`-7L8[L6Y+1!R<
M*2.>AYZ=Z\F^*=SI>CO8>)/"6IV5MJ2SF.X_L^=-TH/S#>JGYAE><CGC->L>
M&=9'B'PO8:L$V&YA#LOHW0_AD&IK8.IAZ4,53;2E==FGV^:Z]==$"DF^5GS]
M\#/^2B#_`*\Y?_9:^F*^9_@9_P`E$'_7G+_[+7>_&#QEJFGW=CX9T.<PW=\`
M99$.'`9MJJ#VR<\^U>]GV#J8S-51I[N*U>R2OJ94I*,+L]+N]>T>PN#;WFK6
M%M,`"8YKE$8`]."<U8L[ZSU&#S[*Z@N8<[?,AD#KGTR*PO"G@K2?#&D16T-K
M'+<E?W]S*@:25CUR?3MCIC\:\\^(^FK\.-2T_P`6^&`MDTTQ@NK5?]5+D;ON
M]`/E.1ZX(QBO!P^$HXFM["E)W>S:T?JNE_F:N32NSVBLI_%'A^.1HWUW3%=3
MM96NXP0?0C-<%\6-<N9?AEI]_8R2?9KRXA^U>03AH61B5+#HI8*/?IWINA_%
M+X>II\6G1VHTZ!TQ)"UJ/+&>#DC[WN>]:4\KJRPZKJ+EJU:/2W??[K?,3FKV
M/4T=9$5T8,C#*LIR"/44ZO+-*T[0K_Q_H6K>$M3ADTZ!K@W-C%-A(2T3+O2(
M],D@'`QTKU.N+%8=4'%)MMJ[35FG=JS7RO\`,J+N>;_%+Q'I$&EZ?:M?P-,N
MJP,ZI(&,81\MN`Y&,&N]LM2L=25FL;VWN0N-QAE#[<],X/%49_"/AJYGDGG\
M/:3+-*Q>222RC9G8G)))7))/>K>G:-I>D"0:9IMG9"3!<6T"Q[\=,[0,]3^=
M;5JN'EAXTX)\T;[VMK;_`"!)WN8WC;P5IWC72#:W:B.ZCR;:Y`^:)OZJ>X_J
M!7S]H.BZMX7^*&CZ+J(DBQJ,$FP,?+EPQ"N.QX+8/;)%?5%5;G3+"\N;>YNK
M&VGGMFW02RQ*S1'U4D94\#IZ5UY=G-3"4IT)KFA)/3LWU7^1,Z:D[G%_%_0;
MK7_`4T=DCR7%K.ERL2+DR`94@?@Q/X5XG\/;JVNKN[\(:P=EGJO[N)G7)@NA
MQ&P'8YX]^G0FOJJLB?PKX=N;IKJXT'2Y;AFW-+)9QLY/J21G-/!YK"G@YX*O
M'FB]4UNG_6H2@W)21\U>.[Z",Z?X1TH"2WTK,<KHHS/='AST!//RCZ5[A\*O
M!DOA#PTWVPL+Z^*RSQGI'@<+]>>:ZF+PYH<%\;Z'1=.CO"Q<W"6J"0L>IW`9
MR:TZ6+S:,\'#!4(\L%O?=O\`X?4(PM+F9Y1\:_!C:UHR:[91J;NP4^:`/FDB
MZ]ADD'G\34_PIN-2\4Z38:QJTCM'ID;6EL&+?O9/XICS\Q"$(#SSOKTZ2..:
M)XI45XW!5E89#`]01W%16=C::=:I:V-K!:VZ9VQ01A$7)R<`<#DDUB\SD\"L
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M/RKU/_A"_"O_`$+.C?\`@!%_\36T45DV,H*],$<5[N)SV,\='&4HO:S3ZHR5
M+W>5F/X6\0V?B?P]::G9OE9$`="1NC8<%6]#FO.OBY+_`,);=Z9X/T93=:BM
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M#(,O"OE.`6(XP21V%>V51LM%TK3)7EL-,L[220!7>"!8RP'0$@<U>J<?C98N
04)3;;BK7>[U;_6PXQY3_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
